You are here

lotiglipron

Pfizer Just Canned One of Its Ozempic Killers. What's Next?

Motley Fool

Mon, 07/3/23 - 10:37 am

Pfizer, citing safety concerns, scraps one of two obesity pill hopefuls

BioPharma Dive

Mon, 06/26/23 - 09:57 am

ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer

EP Vantage

Wed, 06/21/23 - 10:38 am